Coronavirus (COVID-19) Resource Center

Professionals

Name	Title	Office	Email
Chris Bator Cleveland +1.216.861.7372 Counsel Chris Bator	Counsel	Cleveland	cbator@bakerlaw.com
Edward J. Bernert Columbus +1.614.462.2687 Partner Edward J. Bernert	Partner	Columbus	ebernert@bakerlaw.com
Daniel J. Buzzetta New York +1.212.589.4236 Partner Daniel J. Buzzetta	Partner	New York	dbuzzetta@bakerlaw.com
Phillip M. Callesen Cleveland +1.216.861.7884 Partner Phillip M. Callesen	Partner	Cleveland	pcallesen@bakerlaw.com
Christopher J. Carolan New York +1.212.589.4658 Partner Christopher J. Carolan	Partner	New York	ccarolan@bakerlaw.com
Joseph L. Chairez Costa Mesa +1.714.966.8822 Partner Joseph L. Chairez	Partner	Costa Mesa	jchairez@bakerlaw.com
Mark A. Cymrot Washington, D.C. +1.202.861.1677 Partner Mark A. Cymrot	Partner	Washington, D.C.	mcymrot@bakerlaw.com
Sashe D. Dimitroff Houston +1.713.646.1320 Partner Sashe D. Dimitroff	Partner	Houston	sdimitroff@bakerlaw.com
Michael A. Ferguson Washington, D.C. +1.202.861.1663 Senior Advisor Michael A. Ferguson	Senior Advisor	Washington, D.C.	mferguson@bakerlaw.com
David M. Friebus Chicago +1.312.416.6234 Partner David M. Friebus	Partner	Chicago	dfriebus@bakerlaw.com
Lisa M. Ghannoum Cleveland +1.216.861.7872 Partner Lisa M. Ghannoum	Partner	Cleveland	lghannoum@bakerlaw.com
John M. Gherlein Cleveland +1.216.861.7398 Partner John M. Gherlein	Partner	Cleveland	jgherlein@bakerlaw.com
May Tal Gongolevsky New York +1.212.589.4213 Partner May Tal Gongolevsky	Partner	New York	mgongolevsky@bakerlaw.com
Elizabeth A. Green Orlando +1.407.649.4036 Partner Elizabeth A. Green	Partner	Orlando	egreen@bakerlaw.com
Kurt P. Gruber Orlando +1.407.649.4042 Partner Kurt P. Gruber	Partner	Orlando	kgruber@bakerlaw.com
Seth J. Hanft Columbus +1.614.462.4778 Partner Seth J. Hanft	Partner	Columbus	shanft@bakerlaw.com
Michelle M. Hervey Cleveland +1.216.861.7290 Partner Michelle M. Hervey	Partner	Cleveland	mhervey@bakerlaw.com
Susan Whittaker Hughes Cleveland +1.216.861.7841 Partner Susan Whittaker Hughes	Partner	Cleveland	shughes@bakerlaw.com
Nancy Inesta Los Angeles +1.310.442.8833 Partner Nancy Inesta	Partner	Los Angeles	ninesta@bakerlaw.com
Edward J. Jacobs New York +1.212.589.4674 Partner Edward J. Jacobs	Partner	New York	ejacobs@bakerlaw.com
Christian B. Jones Washington, D.C. +1.202.861.1617 Senior Advisor Christian B. Jones	Senior Advisor	Washington, D.C.	cjones@bakerlaw.com
Mark A. Kadzielski Los Angeles +1.310.442.8815 Partner Mark A. Kadzielski	Partner	Los Angeles	mkadzielski@bakerlaw.com
Gilbert S. Keteltas Washington, D.C. +1.202.861.1530 Partner Gilbert S. Keteltas	Partner	Washington, D.C.	gketeltas@bakerlaw.com
Jay P. Krupin Washington, D.C. +1.202.861.1700 Partner Jay P. Krupin	Partner	Washington, D.C.	jkrupin@bakerlaw.com
L. Poe Leggette Houston / Denver +1.713.276.1647 / +1.303.764.4020 Partner L. Poe Leggette	Partner	Houston	pleggette@bakerlaw.com
John R. Lehrer II Washington, D.C. +1.202.861.1620 Partner John R. Lehrer II	Partner	Washington, D.C.	jlehrer@bakerlaw.com
Charlene L. McGinty Atlanta +1.404.256.8232 Partner Charlene L. McGinty	Partner	Atlanta	cmcginty@bakerlaw.com
John Melicharek Jr. Orlando / New York +1.407.649.4086 / +1.212.589.4284 Partner John Melicharek Jr.	Partner	Orlando	jmelicharek@bakerlaw.com
Jennifer A. Mills Cleveland +1.216.861.7874 Partner Jennifer A. Mills	Partner	Cleveland	jmills@bakerlaw.com
William Oxley Los Angeles +1.310.442.8894 Partner William Oxley	Partner	Los Angeles	woxley@bakerlaw.com
Jeffrey H. Paravano Washington, D.C. +1.202.861.1770 Partner Jeffrey H. Paravano	Partner	Washington, D.C.	jparavano@bakerlaw.com
Laurin D. Quiat Denver +1.303.764.4136 Partner Laurin D. Quiat	Partner	Denver	lquiat@bakerlaw.com
Kenneth B. Reisenfeld Washington, D.C. +1.202.861.1545 Partner Kenneth B. Reisenfeld	Partner	Washington, D.C.	kreisenfeld@bakerlaw.com
Jorian L. Rose New York +1.212.589.4681 Partner Jorian L. Rose	Partner	New York	jrose@bakerlaw.com
Lee H. Rosebush Washington, D.C. +1.202.861.1567 Partner Lee H. Rosebush	Partner	Washington, D.C.	lrosebush@bakerlaw.com
Nathan A. Schacht Denver +1.303.764.4029 Partner Nathan A. Schacht	Partner	Denver	nschacht@bakerlaw.com
Michael J. Semes Philadelphia +1.215.564.8270 Of Counsel Michael J. Semes	Of Counsel	Philadelphia	msemes@bakerlaw.com
Lynn Sessions Houston +1.713.646.1352 Partner Lynn Sessions	Partner	Houston	lsessions@bakerlaw.com
Lance L. Shea M.S., J.D. Washington, D.C. +1.202.861.1648 Partner Lance L. Shea M.S., J.D.	Partner	Washington, D.C.	lshea@bakerlaw.com
James A. Sherer New York +1.212.589.4279 Partner James A. Sherer	Partner	New York	jsherer@bakerlaw.com
Janet A. Spreen Cleveland +1.216.861.7564 Partner Janet A. Spreen	Partner	Cleveland	jspreen@bakerlaw.com
Trevor M. Stanley Washington, D.C. +1.202.861.1551 Partner Trevor M. Stanley	Partner	Washington, D.C.	tstanley@bakerlaw.com
Todd J. Thorson Dallas / Houston +1.214.210.1222 / +1.713.751.1600 Partner Todd J. Thorson	Partner	Dallas	tthorson@bakerlaw.com
W. Ray Whitman Houston / Dallas +1.713.646.1367 / +1.214.210.1200 Partner W. Ray Whitman	Partner	Houston	rwhitman@bakerlaw.com

News

News

• 2/10/2022
  Nancy Inesta Shares Thoughts on Loopholes in Vaccine Exemption Process
• 5/13/2021
  Alexa Cellier Presents CLE Seminar on Employer-Mandated Vaccinations
• 5/12/2021
  Sara Goldstein Speaks on COVID-19 Vaccination Records and HIPAA
• 5/4/2021
  Kevin Edgar Speaks on the Future of Financial Regulation After COVID-19
• 4/21/2021
  Nancy Inesta Comments on Issues Surrounding Proof of Employee Vaccination
• 3/31/2021
  David Ebersole Comments on New Ohio Tax Relief Law
• 3/16/2021
  Janine Anthony Bowen Talks about COVID-19 and Empowering Women
• 3/15/2021
  Amy Traub Comments on Vaccine Decisions Facing Many Companies
• 2/22/2021
  Eric Barnum a Speaker for Roundtable Discussion of Employment Litigation and COVID-19
• 2/19/2021
  Lee Rosebush Talks About BakerHostetler's Interactive COVID-19 Vaccination Guide for Providers
• 2/18/2021
  Paul Schmidt Weighs in On Return to the Workplace, Post-Pandemic Office Culture
• 2/10/2021
  Lee Rosebush Discusses BakerHostetler's Interactive Vaccine Rollout Guide for Providers
• 2/5/2021
  Amy Traub Cautions Employers Regarding COVID-19 Policies
• 10/26/2020
  Jeewon Kim Serrato Joins Roundtable Discussion of Privacy During the Pandemic
• 10/20/2020
  John Carney, George Stamboulidis Speak on Key Topics in Government Investigations
• 10/19/2020
  Casie Collignon Discusses Settling Data Breach Class Actions during Pandemic
• 10/19/2020
  Casie Collignon, Alan Friel, Andreas Kaltsounis Speak at Privacy+Security Academy Virtual Forum
• 10/15/2020
  Eric Barnum Speaks on Remote Depositions, Mediations and Hearings
• 10/15/2020
  Lynn Sessions, Ashlee Grant Lead Webinar on COVID-19 and Employment Law`
• 10/1/2020
  Amy Ralph Mudge Joins Discussion of Fraud During COVID-19 Pandemic
• 9/8/2020
  Barron Avery, Phillip Callesen, Michelle Hervey Lead Webinar on CARES Act
• 8/14/2020
  Jay Krupin Speaks to Real Estate Roundtable Regarding Workplace Issues During Pandemic
• 8/12/2020
  Jeffrey Paravano Comments on Executive Order to Defer Payroll Taxes
• 7/14/2020
  Michael Sabella Speaks on ABA Panel About Remote Learning and Working for Law Students and Lawyers with Disabilities
• 7/14/2020
  Patrick Campbell, George Stamboulidis are Speakers for Webinar on CARES Act Fraud Enforcement
• 7/8/2020
  Sabrina Shadi Featured in Article Discussing Employment Issues During Pandemic
• 6/25/2020
  Kristin Yokomoto Discusses Applying for PPP Loan Forgiveness
• 6/2/2020
  John Carney, Jimmy Fokas Speak on "Accounting for Lawyers" Webinar
• 6/2/2020
  Brian Davis, Michael Semes Lead Webinar on Tax Issues in COVID-19 Era
• 5/21/2020
  Mark Kadzielski a Speaker for Webinar on COVID-19 Challenges Facing Healthcare Facilities
• 5/18/2020
  Jeff Paravano Comments on New Guidance for PPP Loan Forgiveness

Publications

Alerts

• 11/9/2021
  The OSHA ETS Mandate Has Been Stayed by the Fifth Circuit Pending Further Court Review. Now What?
• 11/5/2021
  Biden Administration Ends COVID-19 Travel Ban and Implements New International Air Travel Policy
• 11/5/2021
  CMS Issues Emergency Regulations Requiring COVID-19 Vaccination For Workers at Healthcare Facilities Participating In Medicare And Medicaid
• 11/4/2021
  OSHA Releases Much-Anticipated Vaccine Mandate
• 10/14/2021
  Texas Governor Issues Executive Order Limiting Employer Vaccine Mandates
• 8/24/2021
  OSHA Announces New COVID-19 Guidance: What Is Recommended and What Is Not
• 7/29/2021
  CDC Does an About-Face on Mask Guidance for Vaccinated Individuals
• 6/24/2021
  OSHA's COVID-19 "Emergency Rule" Provides Almost No New Guidance
• 6/10/2021
  OSHA Announces COVID-19 Emergency Temporary Standards for the Healthcare Industry
• 6/9/2021
  EEOC Issues Guidance for Employers on COVID-19 Vaccine Mandates and Incentives
• 5/25/2021
  Unmasking COVID-19 Business Restrictions
• 4/26/2021
  Using the Pandemic to Reduce Ohio Real Property Taxes
• 4/20/2021
  California Passes State-Wide Right to Recall Law: What Employers Need to Consider When Rehiring
• 4/16/2021
  The Future of SEC Enforcement Under the Biden Administration
• 3/29/2021
  Biden's New HHS Secretary Promises "Robust Enforcement"
• 3/25/2021
  California Covered Employees Get Up to 80 Hours of COVID-19 Supplemental Paid Sick Leave in New Senate Bill
• 3/15/2021
  FAQs: American Rescue Plan Act of 2021 COBRA
• 3/11/2021
  The Most Important Items in the $1.9T American Rescue Plan Signed Today by President Biden
• 1/26/2021
  Temporary COVID-19 Policies Becoming Permanent
• 12/29/2020
  FAQs: The Consolidated Appropriations Act (Temporarily) Offers Greater Flexibility for Flexible Spending Arrangements
• 12/27/2020
  President Signed Consolidated Appropriations Act that Includes $900 Billion for COVID-19 Relief
• 12/18/2020
  Guidance from the EEOC on the Latest COVID-19 Question: Can Employers Require COVID-19 Vaccines?
• 12/15/2020
  COVID-19 Vaccine: Approval or Authorization?
• 12/14/2020
  SBA and Treasury Department to Increase Scrutiny of PPP Loans
• 11/23/2020
  IRS Employee Retention Tax Credit Guidance for Acquisitions of PPP Borrowers
• 11/19/2020
  IRS-Provided Relief for Certain Opportunity Zone Requirements in Light of COVID-19 Pandemic Creates Year-End Planning Opportunities
• 11/18/2020
  ISS FAQ: Executive Compensation and COVID-19
• 11/18/2020
  New York Governor Temporarily Adjusts Notary Law to Permit Use of 'Audio-Video Technology'
• 9/28/2020
  Whistleblower Complaints Are Skyrocketing Due to COVID-19
• 9/3/2020
  Government Scrutiny of Mismarking Fraud Likely to Increase Amid COVID-19 Market Volatility
• 8/31/2020
  Treasury Allows Employers That Choose Not to Withhold Employee Share of Social Security Taxes Pursuant to Presidential Memorandum to Collect and Pay Those Taxes in 2021
• 8/12/2020
  President Signs Four COVID-19 Relief Orders, Including Deferral of Certain Payroll Tax Obligations
• 8/6/2020
  Employers Sound Alarms Regarding Confusing OSHA Reporting Obligations in Wake of COVID-19 Cases, But It's Back to the Regs for Clarity
• 8/6/2020
  FAQs: WARN Act in the COVID-19 Era
• 7/17/2020
  Two New Colorado Bills Expand Paid Leave Coverage and Protect Employees Who Raise Health and Safety Concerns
• 7/14/2020
  Update on COVID-19 Immigration Restrictions for Schools and Universities
• 7/8/2020
  Fed Formalizes Main Street Lending Program
• 6/26/2020
  SEC Provides Additional Guidance Regarding COVID-19 Disclosures
• 6/26/2020
  SEC's Office of the Chief Accountant Issues a Statement on Continued Importance of Financial Reporting in COVID-19 Environment
• 6/26/2020
  Algorithms and Intentional Discrimination or Implicit Bias? Balancing the Risks and Benefits of Facial Recognition and Artificial Intelligence During the COVID-19 Pandemic and Civil Unrest
• 6/25/2020
  FAQs: COVID-19 – Employee Benefits Updates
• 6/18/2020
  Companies Entering the Disinfectant and Sanitizer Markets Should Proceed With Caution
• 6/16/2020
  Unpacking Antitrust Issues in the Food Industry During the Pandemic
• 6/11/2020
  Business as Usual? Considerations for Employers Before Returning Employees to the Office
• 6/10/2020
  FDA and State Boards of Pharmacy React to COVID-19 – June 10 Update
• 6/8/2020
  New York City Bars Enforcement of Personal Guaranties in Commercial Leases of COVID-19-Impacted Tenants
• 6/4/2020
  President to Sign Paycheck Protection Program Flexibility Act
• 3/23/2020
  Ohio Department of Health: Business Must Cease Unless Essential. Good News, Your Business May Very Well Be Essential
• 3/2/2020
  BakerHostetler Develops COVID-19 Employment Issues Task Force (CEIT) to Address Workplace Concerns

Articles

• 1/27/2022
  Nancy Inesta Addresses Noncompliance Hurdles Faced by Employers Amid Pandemic
• 5/13/2021
  William Bergman Article Examines Calls for COVID IP Waivers
• 4/2/2021
  Lindsay Holmes Authors Article for AHLA on COVID-19 Vaccine Developments
• 3/26/2021
  George Stamboulidis, Patrick Campbell, Christina Gotsis Author Article Examining Expanded Paycheck Protection Program
• 1/20/2021
  Nancy Inesta, Amy Traub Article Discusses Issues for Employers Considering Mandating COVID-19 Vaccine
• 12/31/2020
  George Stamboulidis, Patrick Campbell, Lauren Lyster Author Article Examining Regulatory Risks for CARES Act Borrowers
• 11/2/2020
  Alexa Cellier Article Examines Employer Issues of Families First Coronavirus Response Act
• 10/20/2020
  Michael Sabella, Anat Maytal Author Article Examining How The COVID-19 Pandemic Has Affected Employees with Disabilities
• 6/22/2020
  Ann O'Brien, Brady Cummins Co-Write Price-Gouging Article for ABA's The Antitrust Source
• 6/9/2020
  Amy Traub Co-Authors Analysis of Employer Strategies to Limit COVID-19 Discrimination Claims
• Keith Durkin Article Examines Revised Term Sheets for Main Street Lending Program

Podcasts

• 11/8/2021
  OSHA's Emergency Temporary Standard on Covid-19 Vaccines | What You Need to Know Now to Meet the Short Deadlines for Compliance
• 4/21/2021
  The CARES Act Provider Relief Fund: A Moving Target
• 1/25/2021
  How Will States Tax Forgiven PPP Loans?
• 12/21/2020
  COVID-19 Vaccine: Simplifying the Complex Life Cycle of the Vaccine
• 12/21/2020
  What Employers Need to Know About Vaccine Administration
• 9/23/2020
  Navigating Expense Reimbursement Amidst the New Work-From-Home Normal
• 9/2/2020
  Litigating in a Pandemic: Tips on Dealing with the New Abnormal
• 8/1/2020
  Life Sciences: Connected Medical Devices in the Cloud During COVID-19
• 7/28/2020
  Changes to Business Immigration During COVID-19: What Employers Need to Know

Videos

• 9/30/2020
  Commercial Leasing and COVID-19: What to Expect Next
• 6/23/2020
  The Failing Firm Antitrust Defense – How To Navigate Financially Troubled Mergers During a Pandemic
• 6/11/2020
  Washington's Response to COVID-19: Majority Leader Steny Hoyer, D-Md.
• 6/10/2020
  Washington's Response to COVID-19: Congressman Patrick McHenry, R-N.C.
• 6/3/2020
  Washington's Response to COVID-19: Republican Whip Steve Scalise, R-La.
• 6/2/2020
  Equity Markets and the COVID-19 Pandemic
• 6/1/2020
  Washington's Response to COVID-19: Majority Whip James E. Clyburn, D-S.C.
• 5/27/2020
  Leveraging Business Model Uncertainty to Drive Digital Transformation and Smart Data Strategies
• 5/20/2020
  Accelerate: Getting to Your North Star Faster
• 5/20/2020
  Washington's Response to COVID-19: Senator Cory Booker, D-N.J.
• 5/19/2020
  Washington's Response to COVID-19: Senator John Barrasso, R-Wyo.
• 5/13/2020
  Washington's Response to COVID-19: Congressman Hakeem Jeffries, D-N.Y.
• 5/6/2020
  Positioning for What's Beyond the Horizon: What Digital Transformation and The Data Economy Mean for You
• 4/29/2020
  Fraud and Government Enforcement in Times of Crisis
• 4/23/2020
  Marketing, Promoting and Pricing Your Products During the Pandemic
• 4/21/2020
  Washington's Response to COVID-19: Congressman Michael C. Burgess, M.D., R-Texas
• 4/15/2020
  Fed-Backed Credit Facilities From the CARES Act: Implications for Businesses
• 4/14/2020
  Corporate Disclosure and Enforcement Impact of COVID-19 on SEC Filings
• 4/13/2020
  COVID-19 Pandemic: Antitrust Risks and Possible Protection Under the Defense Production Act and State Action Immunity Doctrine
• 4/6/2020
  Washington's Response to COVID-19: Congresswoman Stephanie Murphy, D-Fla.
• 4/2/2020
  Washington's Response to COVID-19: Senator Roy Blunt, R-Mo.
• 3/31/2020
  $2 Trillion CARES Act Provides Significant Tax and Workforce Relief for Businesses, Individuals

Blog Posts

• 11/5/2021
  UPDATE: Federal Contractor Vaccine Mandate in Flux
• 7/20/2021
  Update on the NY HERO Act: What the NY COVID-19 Worker Protection Law Means for Employers
• 6/14/2021
  Texas Court Affirms Employers' Freedom to Require COVID-19 Vaccine for Employees
• 6/10/2021
  Texas Passes Bill Prohibiting Businesses From Requiring Vaccine Passports for Customers, But Not Employees
• 5/27/2021
  Back to Work: Montana Enacts Pro-Employer Changes to Wrongful Discharge Law While Becoming the First State to Protect Employees Based on Vaccination Status
• 5/26/2021
  California Senate Bill 93: Employers, We Have You Covered
• 5/7/2021
  Deciphering The NY Hero Act: A New NY COVID-19 Worker Protection Law
• 3/22/2021
  Employers May Need to Update Their Severance Agreement Templates by April 1
• 3/18/2021
  COVID-19 Vaccine Paid Leave Law Encourages New Yorkers to Get Vaccinated
• 10/30/2020
  Wielding Trademark Rights to Fight COVID-19 Scams
• 10/12/2020
  Moderna Opens Its IP Vault During the Pandemic to Allow Others to Rely on Its Patented Technologies to Find a Treatment For COVID-19
• 10/2/2020
  NYC Earned Safe and Sick Time Amendments Effective September 30, 2020
• 9/21/2020
  Strategic Considerations for Participation in the USPTO's COVID-19 Deferred-Fee Provisional Application Pilot
• 9/18/2020
  Texas Announces Plan to Ease Restrictions and Allow Expanded Operations of Most Businesses Statewide
• 9/17/2020
  Ohio Enacts House Bill 606, ‘Good Samaritan Expansion Bill,' to Limit Employer Liability for COVID-19 Exposure
• 9/14/2020
  DOL Issues New Guidance on Several FFCRA Issues
• 9/11/2020
  California Enacts COVID-19 Sick Leave for Workers
• 9/10/2020
  Workers' Compensation and Employer Liability in the Era of COVID-19
• 9/2/2020
  Increased Union Activity in the COVID-19 Era
• 7/6/2020
  ‘Something of an Experiment': District of Delaware Prepares for Socially Distanced Patent Trial Tentatively Set for August 2020
• 6/24/2020
  CPRA Moves Forward Despite COVID-19 Woes
• 6/18/2020
  USPTO Grants Relief for Patent Applicants Who Failed to Timely File Patent Applications Due to the COVID-19 Outbreak
• 6/16/2020
  Fast-Track Examination for COVID-19-Related Trademarks and Service Marks
• 6/15/2020
  The Potential Patent Risks Associated with COVID-19 Collaborations
• 6/3/2020
  AB 2457: A Potential Helping Hand for California Employers in a Time of Need
• 6/2/2020
  Accelerate: Getting to Your North Star Faster
• 5/28/2020
  USPTO Further Extends Certain Patent Due Dates Only for Small and Micro Entities
• 5/21/2020
  Key COVID-19 Considerations for U.S. Discovery and Information Governance
• 5/21/2020
  COVID-19 and U.S. Statutes of Limitation
• 5/21/2020
  Adapting E-Discovery Workflows to a Remote Work Environment
• 5/20/2020
  The Failing Firm Defense in Times of Economic Uncertainty

Events

• 11/5/2021
  What to Do When OSHA Releases Its Emergency Temporary Standard for Mandatory Employee Vaccinations
• 9/23/2020
  Webinar: Antitrust Issues in the Food Industry During the Pandemic
• 6/3/2020
  Webinar Series: Washington's Response to COVID-19: Republican Whip Steve Scalise, R-La.
• 6/1/2020
  Webinar Series: Washington's Response to COVID-19: Majority Whip James E. Clyburn, D-S.C.
• 3/24/2020
  Managing COVID-19 Webinar Series: Critical Legal Issues For U.S. Businesses & Their Counsel